PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation.

Mouse / Radiation

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22559205 ↗2012Reported benefit

Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation.

MouseRadiationRecipients Balb/c and CD2F1; donor cells pooled from AKR, C57Bl/6 and FVB miceMaleIntravenous transfusionVarious cell doses, including 5 million cells (dose-reducti…From 24 h up to 7 days after irradiation

Model: Lethal total body irradiation with 60Co gamma rays (9.2 Gy and up to 15 Gy, CD2F1) or X-rays (9 Gy, Balb/c)

Cryopreserved allogeneic myeloid progenitor cells significantly improved 30-day survival in both strains after lethal irradiation. The benefit was cell-dose dependent and remained significant when administration was delayed up to 7 days, and up to 5 days at doses as high as 14 Gy.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.